Trials / Conditions / MSI-H/dMMR Gastric Cancer
MSI-H/dMMR Gastric Cancer
3 registered clinical trials studyying MSI-H/dMMR Gastric Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in NCT07262619 | Eikon Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer NCT06250036 | Royal Marsden NHS Foundation Trust | Phase 2 |
| Active Not Recruiting | A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroes NCT06116136 | Servier Bio-Innovation LLC | Phase 1 / Phase 2 |